Evaluation of Transdermal Nicotine Replacement Therapy (NRT) Activity Through Metabolic Induction

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

July 31, 2015

Study Completion Date

September 30, 2015

Conditions
SmokingAddiction
Interventions
DRUG

Nicabate 21mg transdermal NRT

Nicabate 21mg Transdermal NRT Patch applied daily for 14 days Testing at Baseline, Day 4, Day 14 and 14 days post.

Trial Locations (1)

5044

Kristin Carson, Adelaide

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Basil Hetzel Institute for Translational Research

UNKNOWN

collaborator

University of Adelaide

OTHER

collaborator

University of South Australia

OTHER

collaborator

Clinical Practice Unit

UNKNOWN

collaborator

Therapeutics Research Centre

UNKNOWN

lead

The Queen Elizabeth Hospital

OTHER

NCT01438944 - Evaluation of Transdermal Nicotine Replacement Therapy (NRT) Activity Through Metabolic Induction | Biotech Hunter | Biotech Hunter